Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Immunoglobulin G × 30 days × Clear all

Sponsor

Conditions

Lung Neoplasms 12 Carcinoma, Non-Small-Cell Lung 9 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Urinary Bladder Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Nasopharyngeal Carcinoma 3 Fallopian Tube Neoplasms 3 Carcinoma, Hepatocellular 3 Urethral Neoplasms 2 Ureteral Neoplasms 2 Triple Negative Breast Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Lymphoid Interstitial Pneumonia 2 Endometrial Neoplasms 2 Carcinoma, Merkel Cell 2 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Tongue Neoplasms 1 Salivary Gland Neoplasms 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Prostatic Neoplasms 1 Papillary renal cell carcinoma, sporadic 1 Oropharyngeal Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Nasopharyngeal Neoplasms 1

Interventions

Cyclophosphamide 12 Rituximab 11 obinutuzumab 9 fludarabine 9 Prednisone 7 ibrutinib 6 Lenalidomide 6 tocilizumab 5 fludarabine phosphate 5 Biopsy 5 venetoclax 4 pirtobrutinib 4 glofitamab 4 Specimen Handling 4 Doxorubicin 4 polatuzumab vedotin 3 X-Rays 3 Vincristine 3 Phantoms, Imaging 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 tucatinib 2 temsirolimus 2 pertuzumab 2 palbociclib 2 olaparib 2 cobimetinib 2 Whole-Body Irradiation 2 Vemurafenib 2 Trastuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡